From immunostaining, we also observed significantly upregulated SON and PTBP1 in a GBM patient sample in which SOX2 expression, a well-known GBM stemness marker, was highly expressed (Fig. 1h and Supplementary Fig. 4). Here, SON is linked to glioblastoma.